by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

ABS Corporation Warning Letter Details

Warning Letter

ABS Corporation

7031 N 16th St. Omaha , NE 68112 United States

Issue DateJuly 23, 2026

FEI Number1950042

Violations4

CountryUnited States

Issuing Office

Center for Veterinary Medicine

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

ABS Corporation FDA Warning Letter, July 23, 2026